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Background: Prior animal model and human-based studies have linked selenium concentrations to decreased risk
for depression; however, this work has not focused on household groundwater levels or specific depressive
symptoms. The current study evaluated the link between groundwater selenium levels and depression. We also
sought to determine if a functional polymorphism in the glutathione peroxidase 1 (GPX1) gene impacted this link.
Methods: We used a cross-sectional design to analyze data from 585 participants (183 men and 402 women) from
Project FRONTIER, a study of rural health in West Texas. Residential selenium concentrations were estimated using
Geospatial Information System (GIS) analyses. Linear regression models were created using Geriatric Depression
Scale (GDS-30) total and subfactor scores as outcome variables and selenium concentrations as predictor variables.
Analyses were re-run after stratification of the sample on GPX1 Pro198Leu genotype (rs1050454).
Results: Selenium levels were significantly and negatively related to all GDS and subfactor scores accounting for up
to 17% of the variance beyond covariates. Selenium was most strongly protective against depression among
homozygous carriers of the C allele at the Pro198Leu polymorphism of the GPX1 gene. Analyses also point towards
a gene-environmental interaction between selenium exposure and GPX1 polymorphism.
Conclusion: Our results support the link between groundwater selenium levels and decreased depression
symptoms. These findings also highlight the need to consider the genetics of the glutathione peroxidase system
when examining this relationship, as variation in the GPX1 gene is related to depression risk and significantly
influences the protective impact of selenium, which is indicative of a gene-environment interaction.
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Depression is the most frequently occurring psychiatric
disorder [1] with 1 in 10 adults reporting depression [2].
Depression has been shown to have a wide variety of ad-
verse health outcomes including poorer physical and social
functioning, and decreased quality of life [3-5] as well as an
increase in morbidity and mortality [6-8]. Understanding
the link between depression and environmental factors that
may influence its occurrence, symptom presentation, and* Correspondence: leigh.johnson@unthsc.edu
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reproduction in any medium, provided the orseverity, may have a significant impact on our understan-
ding of the biological mechanisms underlying depression
and its treatment. Past research has shown relationships
between depression and environmental factors, such as
natural sour gas containing H2S [9] and pesticides [10].
Another naturally occurring substance that has been
related to depression is selenium.
Past research has shown that selenoproteins are essential
for numerous biological functions [11], many of which are
thought to be related to depression. Depression is thought
to be unpinned by multiple pathways, such as inflamma-
tion, oxidative and nitrosative stress, as well as a decrease
in antioxidant levels [12-14]. Selenium, in the form of Sele-
noprotein P, protects the brain against oxidative damagel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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response [11]. Additionally selenium, an antioxidant and an
essential component in the glutathione peroxidase system,
protects lipids in polyunsaturated membranes from oxida-
tive degradation. Depression is often associated with lower
levels of antioxidants, such as glutathione and GPx, gluta-
thione peroxidase enzyme [16,17]. These findings suggest
that selenium may be protective against depression, and
selenium supplementation may have the potential to alle-
viate the symptoms of depression. However, research inves-
tigating the relationship between selenium and depression
has yielded inconsistent findings. Low selenium concentra-
tions have been related to increased incidence of many
human diseases including depression [18-20]. Rayman et al.
[21] failed to identify any benefit in mood or quality of life
in a sample of elderly participants. Prenatal selenium sup-
plementation has been linked to increased serum selenium
levels as well as decreased risk for postpartum depression
[22]. Pasco et al. [23] found that lower dietary selenium was
related to a new diagnosis of major depression. Recently,
Gao et al. [24] found that higher selenium were associated
with lower GDS scores; however this effect was no longer
significant when cognitive functioning was added to the
model. This finding is interesting because it suggests that
the link between selenium and depression may be impacted
by individual factors, such as genetic variants that may
impact the selenium levels in the body.
Selenium also plays a key role in proper functioning of
the glutathione peroxidase system, which has been linked
to depression. The glutathione peroxidase enzyme (GPx)
is expressed in lower amounts among depressed patients,
and GPx activity has been linked to depressed mood and
autonomic symptoms [25]. Because functional variants
have been identified within glutathione peroxidase genes,
genetic variation within the glutathione peroxidase
pathway is an important consideration when examining
selenium-health status links. In particular, the Pro198Leu
polymorphism of the glutathione peroxidase 1 (GPX1)
gene (rs1050454) has received a great deal of attention re-
cently in the literature [26]. This polymorphism contains a
c.599C>T SNP, which is also referred to as rs1050450.
The single nucleotide polymorphism (SNP) likely affects
the activity of variant proteins [27]. The T allele of the
rs1050450 GPX1 SNP has been associated with bladder,
lung, and breast cancers, intracerebral hemorrhage [28],
metabolic syndrome [29], and coronary artery disease
[30]. It is functional in humans and impacts the response
of GPX1 activity to selenium [31]. Genetic polymorphisms
of the GPX1 gene have been shown to be related to tumor
susceptibility [32], blood selenium levels associated
with supplementation [33], and other health conditions.
However, to date, we are aware of no studies that have
examined the impact of GPX1 polymorphisms on the
selenium- depression link.The current study was designed to (a) study the link
between groundwater selenium levels and depressive
symptoms, (b) determine if the Pro198Leu GPX1
directly impact depression risk, and (c) determine if the
Pro198Leu polymorphisms of the GPX1 gene impact
these findings. It was hypothesized that higher ground-
water selenium would be protective against depressive
symptoms. No specific a priori hypotheses were made
regarding the Pro198Leu polymorphism given that this




Data were analyzed from 585 participants (183 men and
402 women) from Project FRONTIER. Project FRONTIER
is an ongoing study of factors impacting rural health that
utilizes a community-based participatory research (CBPR)
approach. The CBPR approach of partnering with commu-
nity members and organizations is particularly useful when
working with underserved communities, thus it is very well
suited to rural health research and has been recommended
by the National Institute on Environmental Health Sciences
[34]. All participants signed written informed consents.
Once participants have completed the consent process,
s/he undergoes an interview (participant and informant), a
standardized medical examination, clinical labs, and neuro-
psychological testing. Inclusion criteria are (a) age 40 and
above and (b) residing in one of the counties included in
Project FRONTIER. The counties currently included in
project FRONTIER are Cochran County, Bailey County,
and Parmer County, all of which are located on the
Texas – New Mexico border. Participant recruitment is
completed by community recruiters/assessors through
multiple means including brochures/flyers, presenta-
tions and events, in-person and/or door-to-door solicita-
tion, as well as snowball recruitment. Our prior work has
shown that the research sample closely matches the
demographics of the community at large [34]. Project
FRONTIER is conducted under an IRB approved proto-
col. We have published findings utilizing this approach
with Project FRONTIER elsewhere [35-37]. Project
FRONTIER is conducted under the approval of Texas
Tech Health Sciences Center IRB Board, L06-028.
This archival analysis was conducted from a de-identified
database under the approval of the University of North
Texas Health Sciences Center IRB Review Board, protocol
number 2012-071.
Measures
Geriatric depression scale (GDS-30)
The Geriatric Depression Scale was created specifically
for screening depressive symptoms among older popula-
tions [38], and has been widely utilized in both clinical
Table 1 Demographic characteristics
Mean (sd) Range
Age 61.45 (12.70) 40-96
Education 10.76 (4.37) 0-20
GIS-selenium (μg/L) 17.70 (10.67) 3.96-56.32
GDS Total 10.49 (5.07) 0-26
GDS Dysphoria 3.31 (2.44) 0-11
GDS Meaninglessness 2.24 (1.43) 0-7
GDS Apathy 2.87 (1.42) 0-6
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adequate internal consistency, test–retest reliability, and
concurrent validity [39]. A recent factor analytic study
[40] identified a four- factor solution underlying the
scale. The Dysphoria factor contains 11 items primarily
associated with a sad mood; the Meaninglessness factor
consists of seven items that reflect an appraisal of the
meaning (or lack thereof ) in one’s life; the Apathy factor
is made up of six items that reflect a lack of motivation
or initiative; finally, the Cognitive Impairment factor
consists of six items that reflect difficulty and concern
with cognitive processes.
Determination of GIS-selenium
Geographic information system (GIS) analysis is a way of
displaying and analyzing geographically referenced informa-
tion that is frequently used to estimate environmental
exposures [35,41-46]. We used the Environmental Systems
Research Institute ArcGIS (release 9.2) program to plot
a point for each of the selenium ground water measure-
ments from the Texas Water Development Board (TWDB).
Through inverse distance weighted (IDW) interpolation,
the ArcGIS software built a three-dimensional surface map
from a list of points. Each point’s influence was weighted
based off its distance to that section of the map, which was
generated using 12 well measurements from the TWDB
within the immediate geographic vicinity. Each of the study
participant’s current residential address was geocoded with
the ArcGIS StreetMap data. Finally, GIS-selenium concen-
tration was calculated by extracting the estimated selenium
value from the IDW surface at each resident’s location. The
inter-rater reliability of our GIS approach to calculating our
groundwater elements is very high (Pearson Correlation co-
efficient > 0.9). In our prior work, we have found our GIS-
based estimates to be very similar to concentrations found
from direct measurement [35].
Polymerase chain reactions (PCRs) were utilized to
genotype the GPX1 (rs1050450) polymorphism. Primers
were purchased from Integrated DNA Technologies, Inc.:
FW 50- CTACGCAGGTACAGC-CGCCGCT-30 and RV
50-AAGGTGTTCCTCCCTCG-TAGGT-30. Amplification
conditions included: 100ng template DNA, DMSO, water,
and GoTaq Green Master Mix (3mM MgCl2, 1X PCR
buffer, 400 μM each dNTP). The amplicons of the GPX1
gene were digested with the restriction enzyme Apa1 with
0.18 μL per sample, 0.05 μL BSA, and 1 μL 10x buffer 4,
leaving fragment sizes determined by the genotype of the
studied individuals (pro/pro = 191 bp; pro/leu = 191, 117,
and 74 bp; leu/leu = 117 and 74 bp). Digested fragments
were separated on 1% agarose and visualized by ethidium
bromide staining.
In order to examine the link between groundwater sele-
nium exposures and affective status, linear regression
models were created with SPSS version 18 using GDS-30(total and subfactor) scores as outcome variables and sele-
nium concentration as the predictor variables. Covariates
entered into the models were age, gender, education, and
language of administration. In order to obtain magnitude of
relations, the amount of variance accounted for by
selenium concentrations alone is also presented. Logistic
regression models were created to determine the risk of
depression, defined as GDS score ≥ 10, that were asso-
ciated with (a) groundwater selenium concentrations and
(b) the GPX1 Pro198Leu polymorphism.
Results
The mean age and education of the sample was 61.49 (sd =
12.70; range = 40-96) and 10.76 (sd = 4.37; range = 0-20),
respectively. Mean GIS-based selenium concentration was
17.70 μg/L (sd = 10.66; range = 3.96-56.32). Seventy-seven
percent of the sample was interviewed in English and 33%
in Spanish; 88% of the sample self-reported their race as
White, and 38% reported their ethnicity as Mexican
American. Mean GDS-30 score of the sample was 10.49
(sd = 5.07; range = 0-26). Demographic characteristics of
the sample are presented in Table 1.
Selenium concentrations were found to be significantly
and negatively related to all GDS scores. Specifically,
higher selenium levels were significantly related to lower
scores in the Total GDS-30 scores (β = -0.34, p < 0.001),
explaining 11% of the variance. Higher selenium was
also related to a decrease in factor scores of Dysphoria
(β = -0.23, p < 0.001), explaining 5% of the variance,
Meaninglessness (β = -0.42, p < 0.001), explaining 17%
of the variance, and Apathy (β = -0.30, p < 0.001),
explaining 9% of the variance. Higher selenium concen-
tration was statistically a significant predictor of lower
scores on the subfactor of Cognitive Impairment (β = -0.11,
p = 0.01), but only accounted for 1% of the variance. The
results of the regression analysis can be found in Table 2.
Higher selenium concentration was also associated with a
Table 2 Linear regression results
B (SE) t-score p-value % Variance accounted For
GDS Total −0.16 (0.02) −8.21 0.000 11%
GDS Dysphoria −0.05 (0.01) −5.24 0.000 5%
GDS Meaninglessness −0.06 (0.006) −10.31 0.000 17%
GDS Apathy −0.04 (0.006) −7.11 0.000 9%
GDS Cognitive Impairment −0.13 (0.005) −2.53 0.012 1%
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(SE = 0.01), Wald (df = 1) = 37.25, p < 0.001, and
OR = 0.94 (95% CI = 0.92-0.96).
The link between depression and GPX1 polymorp-
hisms was strongest for CC (homozygous wild type)
and TT (homozygous mutant type) carriers, with the
greatest impact being for TT individuals as shown in
Table 3. The TT polymorphism was the least frequent
in the sample; however, for TT individuals, selenium
concentrations accounted for 26% of the variance in
GDS Total Score, 13% of the variance in Dysphoria,
37% of the variance in Meaninglessness, and 19% of
the variance in Apathy. For the CC polymorphism,
selenium concentrations accounted for 15% of the
variance in total score, 9% of the variance in Dysphoria,
22% of the variance in Meaninglessness, and 14% of the
variance in Apathy. The amount of variance for CT
polymorphism was relatively small.
Next, we examined the impact of the GPX1 Pro198Leu
polymorphism on the findings. First, we sought toTable 3 Linear Regression Results by GPX1 Allele
B (SE) t-score
CC (n = 221)
GDS Total −0.18 (0.03) −6.40
GDS Dysphoria −0.05 (0.02) −3.24
GDS Meaninglessness −0.06 (0.007) −8.04
GDS Apathy −0.05 (0.008) −6.10
GDS Cognitive Impairment −0.02 (0.007) −2.96
CT (n = 208)
GDS Total −0.13 (0.04) −3.58
GDS Dysphoria −0.05 (0.02) −2.99
GDS Meaninglessness −0.05 (0.01) −4.68
GDS Apathy −0.03 (0.01) −2.74
GDS Cognitive Impairment 0.00 (0.008) −0.05
TT (n = 33)
GDS Total −0.27 (0.07) −3.78
GDS Dysphoria −0.08 (0.04) −2.27
GDS Meaninglessness −0.11 (0.2) −5.11
GDS Apathy −0.06 (0.02) −2.81
GDS Cognitive Impairment −0.02 (0.3) −0.73determine if homozygous carriage of the C allele was asso-
ciated with depression status (GDS ≥ 10 = depressed),
compared to T allele carriers (CT plus TT; TT was not
analyzed separately due to sample size). Logistic regression
was conducted with depressed status as the outcome vari-
able and GPX1 polymorphism (CC versus CT) as a
categorical predictor variable. Sixty-six percent of CC
homozygotes were depressed compared to 57% for T allele
carriers; therefore, homozygous carriage of the C allele was
associated with a significantly increased risk of depression
(B = 0.50, SE = 0.19, Wald (df = 1) = 6.88, p = 0.009, and
OR = 1.65 (95% CI = 1.14-2.40). Next, a linear regression
model was created to examine the gene-dose effect of
GPX1 C versus T (CC = 2, CT = 1, TT = 0) alleles on
depression scores (GDS total score). With age, gender,
education, and test language entered as covariates, the
increasing presence of the T allele was associated with sig-
nificantly higher GDS scores (B = 0.94, SE = 0.35, t = 2.69,
and p = 0.008). Lastly, we re-ran our regression analyses
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of the sample on genotype at the GPX1 Pro198Leu
polymorphism. The link between selenium levels and
depression was strongest among CC and TT, as compared
to CT individuals. The TT polymorphism was the least
frequent in the sample. Of note, in regression analysis of
groundwater selenium levels on depression risk, models
that included Pro198Leu genotype along with age, gender,
education, and language of test administration accounted
for more variance (70%) than those that did not include
genotypic status (50%). For CC polymorphism, selenium
concentrations alone accounted for 15% of the variance in
total score, 9% of the variance in dysphoria, 22% of the
variance in meaninglessness, and 14% of the variance in
apathy, which was more variance accounted for than
found by covariates. The amount of variance for CT
polymorphism was relatively small. See Table 3.
Therefore, these findings point to a gene-environment
interaction, which is supported by the gene-dose findings.
Discussions and conclusions
In the past three decades, selenium has been found to be
essential to various aspects of health [47]. It has been
found to play a role in prevention of cancer and cardiovas-
cular disease as well as in regulating mood [20]. Exposure
to environmental factors, such as selenium, can also play a
role in depression and anxiety states. Past research has
shown that low selenium concentrations were related
to depression status and other negative affective states
[18,20]. In addition, studies have indicated that selenium
may be useful in preventing postpartum depression [22].
In the current study, higher groundwater selenium
levels were associated with lower scores on the Geriatric
Depression Scale. This finding is consistent with past re-
search indicating that low selenium status is related to
increased incidence of depression and other negative
affective states [18,20]. In addition to the decrease in
total depression scores, higher selenium levels were spe-
cifically related to a decrease in symptoms of Dysphoria,
Meaninglessness, and Apathy, indicating that selenium
may have an impact on particular types of depressive
manifestations. It is interesting to note that selenium
concentrations were only minimally related to the cogni-
tive impairment subscale, as we have previously shown
selenium to be selectively protective of memory func-
tioning [36]. This suggests that, despite the potential role
of selenium concentrations in preserving cognitive
function, depressive symptoms related to thoughts of
cognitive dysfunction appear to be unrelated and may
be related to the concept of insight.
This is the first study to examine residential groundwater
selenium levels and depression. A myriad of factors deter-
mine the chemical make-up of groundwater in a given area,and it is important to be cognizant of the potential health
impacts from such substances. Research on groundwater
and its implications on human health can have profound
implications in the realms of public health and policy.
Additionally, results obtained by groundwater research
could prove to be the impetus for the formation or refor-
mation of population-based prevention strategies concer-
ning groundwater safety and exposure. This study was
conducted in a rural agricultural area where higher concen-
trations of groundwater selenium are typically found.
Aligning with this, the mean selenium level in this study
was 17.70 μg/L, whereas the national average is 10 μg/L
[48].
The protective impact of selenium on mental health fits
with its biological activity and is supported by both animal
model and human research. Selenium, a main constituent
of neuronal selenoproteins, may be particularly important
for sustaining healthy cerebral function [47] through its key
role in protection against oxidative damage [15,20,49]. Oxi-
dative damage is a key biological mechanism in depression
pathophysiology, and many anti-depressants, like fluoxetine
[50] and venlafaxine [51], reduce oxidative damage. An-
other possible mechanism of action is through selenium’s
impact on brain-derived neurotrophic factor (BDNF), which
has been linked to depression and found to be decreased in
selenium deficient rats [52]. Additionally, depression is also
associated with lower antioxidant levels. Research has sug-
gested that antioxidant deficiency found in depression may
predispose individuals to greater inflammatory and oxida-
tive and nitrosative responses [13], which may contribute to
the protective effects of selenium against depression.
Ours is the first study to directly examine the link
between the GPX1 Pro198Leu polymorphism and depres-
sive risk as well as its impact on the selenium-depression
link. Our findings point to gene-environment interaction,
which is supported by the gene-dose impact. Specifically,
the C allele of the GPX1 polymorphism was associated
with significantly increased risk of depression in a dose-
dependent manner (i.e. CC > CT > TT). Additionally, the
impact of environmental selenium concentrations on de-
pression scores was stronger for the CC than CT group.
The TT group showed a substantial impact in the expected
direction, but due to the small sample number of TT
homozygotes, these results must be replicated. It is also im-
portant to note the differences in effect sizes for selenium
on depression observed in each genotypic group. Among
CC homozygotes, the majority of variance accounted for in
GDS scores was from selenium concentrations with age,
gender, education, and language of test administration con-
tributing less to GDS scores. Among the TT group, the
amount of variance accounted for by selenium concentra-
tions alone was substantial; however, covariates in the
model also accounted for a larger portion of the variance.
Future work is needed to delve more thoroughly into this
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impact of the C allele of the GPX1 polymorphism on risk
for depression. Additional work is also required to examine
other potential genes of interest. For example, Galecki and
colleagues [53] identified polymorphisms of the NOS2A
gene, which are important in the nitric oxide pathways, as
related to recurrent depression. Given that selenium (i.e.
selenoproteins) is involved in the nitric oxide pathway as
well, NOS2A and other genes relevant to pathways linked
to selenium should be examined. It is likely that more
sophisticated bioinformatic analyses will be necessary to
disentangle these multi-level gene-(biological mechanism)
– environmental exposure – depression interactions.
These results point towards possible pharmacogenetic
implications of the Pro198Leu GPX1 polymorphism. Spe-
cifically, in our sample, CC homozygotes had significantly
increased risk for depression; however, selenium was also
most powerfully protective against depression and depres-
sive symptoms among those particular carriers. Therefore,
future research looking at the therapeutic impact of se-
lenium on depression should examine this genotype.
Additionally, previously conducted clinical trials of anti-
depressant medications with stored DNA (or previously
conducted genetic analyses) can determine if Pro198Leu
GPX1 genotype predicts optimal treatment response.
Lastly, the Pro198Leu GPX1 polymorphism may be useful
for identifying those individuals most likely to benefit
from anti-depressant medications in new clinical trials.
There are limitations to the current study. One is the
GIS-based estimate of selenium concentration rather than
direct measurement. However, our prior work, as well as
that of others, has shown that GIS-based methods are valid
ways for estimating environmental exposures. The current
findings should be replicated using direct selenium meas-
urement. The cross-sectional nature of the study is another
limitation; however, our prior work has shown selenium to
be preventative of cognitive decline prospectively in a sub-
set of this cohort [30]. Future studies will examine the
protective impact of selenium concentrations on both
depression and cognitive decline as future waves become
available. The current study also has several strengths.
Specifically, this is the first study to examine this link
in such detail (i.e. depressive symptoms rather than
only global scores) as well as look at this topic among
rural-dwelling adults and elders. This is also the first
study to examine the impact of genetic variation within
GPX1 on depression risk as well as the selenium-
depression link. Taken together, these results point to the
need for continued work in the area, as selenium may
provide a therapeutic target for preventative strategies
aimed at reducing depressive incidence rates in vulnerable
populations. Additional work is also needed to determine
the pharmacogenetic implications of the Pro198Leu GPX1
polymorphism in depression therapies.Abbreviations
CBPR: Community-based participatory research; GDS: Geriatric depression
scale; GIS: Geospatial information system; GPX1: Glutathione peroxidase 1;
SNP: Single nucleotide polymorphism; TWDB: Texas water development
board; BDNF: Brain-derived neurotrophic factor; PCRs: Polymerase chain
reactions; CC: Homozygous wild type alleles; TT: Homozygous mutant type
alleles.
Competing interests
The authors declare no competing financial interests. This work was funded
in part by the Science To Achieve Results (STAR) Program of the U.S.
Environmental Protection Agency (EPA) grant # RD83479401 (O’Bryant, PI),
National Institute on Minority Health and Health Disparities (NIMHD) award
#L60MD001849 and the Hogg Foundation grant # JRG-040 (O’Bryant, PI).
Authors’ contributions
LJ: Designed the study, participated in data collection and analysis, and
manuscript preparation. JP: Participated in data collection, entry, and
manuscript preparation. CM: Participated in data collection and manuscript
preparation. ME: Participated in data collection, and manuscript preparation.
VB: Participated in data collection, analysis, and manuscript preparation. JH:
Assisted in study design, data analysis, and manuscript preparation. RB:
Assisted in study design, data analysis, and manuscript preparation. TC:
Assisted in data analysis, and manuscript preparation. EH: Participated in
manuscript preparation. SO: Designed the study, participated in data
collection and analyses, and manuscript preparation. All authors have read
and approved this manuscript.
Acknowledgements
This work was funded in part by the Science To Achieve Results (STAR)
Program of the U.S. Environmental Protection Agency (EPA) grant #
RD83479401 (O’Bryant, PI), and the Hogg Foundation grant # JRG-040
(O’Bryant, PI). We would like to thank all of the participants of Project
FRONTIER along with the incredible support staff that make this study
possible.
Author details
1Department of Internal Medicine, Institute for Aging & Alzheimer’s Disease
Research, University of North Texas Health Science Center, 3500 Camp Bowie
Blvd, Fort Worth, TX 76107, USA. 2Department of Psychology, Texas Tech
University, Lubbock, TX, USA. 3Department of Psychology, University of North
Texas, Denton, TX, USA. 4Department of Internal Medicine, University of
North Texas Health, Science Center, Fort Worth, TX, USA. 5Department of
Psychiatry, University of North Texas Health Science Center, Fort Worth, TX,
USA. 6Department of Pharmacology & Neuroscience, Institute for Aging &
Alzheimer’s Disease Research, University of North Texas Health Science
Center, Fort Worth, TX, USA. 7Department of Internal Medicine, University of
North Texas Health Science Center, Fort Worth, TX, USA. 8Texas College of
Osteopathic Medicine, University of North Texas Health Science Center, Fort
Worth, TX, USA. 9Department of Internal Medicine, Institute for Aging &
Alzheimer’s Disease Research, University of North Texas Health Science
Center, Fort Worth, TX, USA.
Received: 27 July 2012 Accepted: 19 December 2012
Published: 4 January 2013
References
1. Diabetes surveillance, 1999, 2000; 2000. www.cdc.gov/diabetes/statistics.
surv199/>June 2002.
2. CDC: Current depression among adults - united states, 2006 and 2008.
MMWR 2010, 59(38):1229–1235.
3. Gosney MA, Hammond MF, Shenkin A, Allsup S: Effect of micronutrient
supplementation on mood in nursing home residents. Gerontology 2008,
54(5):292–299.
4. Arnold B, Montgomery G, Castaneda I, Longoria R: Acculturation and
performance of Hispanics on selected halstead-reitan
neuropsychological tests. Assessment 1994, 1:239–248.
5. Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC: Disabilities
and quality of life in pure and comorbid generalized anxiety disorder
and major depression in a national survey. Int Clin Psychopharmacol 2000,
15(6):319–328.
Johnson et al. BMC Psychiatry 2013, 13:7 Page 7 of 8
http://www.biomedcentral.com/1471-244X/13/76. Beekman ATF: The association of physical health and depressive
symptoms in the older population: Age and sex differences. Soc
Psychiatry Psychiatr Epidemiol 1995, 30(1):32–38.
7. Geerlings SW, Beekman ATF, Deeg D, van Tilburg W: Physical health and
the onset and persistence of depression in older adults: an eight-wave
prospective community-based study. Psychol Med 2000,
30(2):369–380.
8. Watson GS, Craft S: The role of insulin resistance in the pathogenesis of
Alzheimer’s disease: implications for treatment. CNS Drugs 2003,
17(1):27–45.
9. Saadat M, Zendeh-Boodi Z, Ali Goodarzi M: Environmental exposure to
natural sour gas containing sulfur compounds results in elevated
depression and hopelessness scores. Ecotoxicol Environ Saf 2006,
65(2):288–291.
10. Beseler C, Stallones L, Hoppin J, Alanvanja MCR, Blair A, Keefe T, Kamel F:
Depression and pesticide exposures in female spouses of licensed
pesticide applicators in the agricultural health study cohort. J Occup
Environ Med 2006, 48(10):1005–1013.
11. Van Cauwenbergh RV, Robberectht H, Va Vlaslaer V: Comparison of the
serum selenium content of healthy adults living in the Antwerp region
(Belgium) with recent literature data. J Trace Elem Med Biol 2004,
18:99–112.
12. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob
P, Lerer B, Maj M: The inflammatory & neurodegenerative (I&ND)
hypothesis of depression: leads for future research and new drug
developments in depression. Metab Brain Dis 2009, 24(1):27–53.
13. Maes M, Galecki P, Chang YS, Berk M: A review on the oxidative and
nitrosative stress (O&NS) pathways in major depression and their
possible contribution to the (neuro)degenerative processes in that
illness. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(3):676–692.
14. Ozdemir E: Physiopathological role of selenium and selenoprotein in
neuropsychiatry disease. J Med Sci 2011, 11(1):11–18.
15. Mostert V: Selenoprotein P: properties, functions, and regulation. Arch
Biochem Biophys 2000, 376(2):433–438.
16. Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, Tvrzická E,
Zák A: Antioxidative enzymes and increased oxidative stress in
depressive women. Clin Biochem 2009, 42(13–14):1368–1374.
17. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O: Antioxidant enzyme
activities and oxidative stress in affective disorders. Int Clin
Psychopharmacol 2004, 19(2):89–95.
18. Hawkes WC, Hornbostel L: Effects of dietary selenium on mood in healthy
men living in a metabolic research unit. Biol Psychiatry 1996,
39(2):121–128.
19. Papp LV, Holmgren A, Khanna KK: Selenium and selenoproteins in health
and disease. Antioxid Redox Signal 2010, 12(7):793–795.
20. Rayman MP: The importance of selenium to human health. Lancet 2000,
356(9225):233–241.
21. Rayman M, Thompson A, Warren-Perry M, Galassini R, Catterick J, Hall E,
Lawrence D, Bliss J: Impact of selenium on mood and quality of life: a
randomized, controlled trial. Biol Psychiatry 2006, 59(2):147–154.
22. Mokhber N, Namjoo M, Tara F, Boskabadi H, Rayman MP, Ghayour-
Mobarhan M, Sahebkar A, Majdi MR, Tavallaie S, Azimi-Nezhad M, et al:
Effect of supplementation with selenium on postpartum depression: a
randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal
Med 2011, 24(1):104–108.
23. Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz
MA, Nicholson GC, Ball MJ, Berk M: Dietary selenium and major
depression: a nested case- control study. Complement Ther Med 2012,
20(3):119–123.
24. Gao S, Jin Y, Unverzagt F, Liang C, Hall K, Cao J, Ma F, Murrell J, Cheng Y, Li
P, et al: Selenium level and depressive symptoms in a rural elderly
Chinese cohort. BMC Psychiatry 2012, 12(1):72.
25. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E:
Lower whole blood glutathione peroxidase (GPX) activity in depression,
but not in myalgic encephalomyelitis / chronic fatigue syndrome:
another pathway that may be associated with coronary artery disease
and neuroprogression in depression. Neuroendocrinol Lett 2011,
32(2):133–140.
26. Soerensen M, Christensen K, Stevnsner T, Christiansen L: The Mn-
superoxide dismutase single nucleotide polymorphism rs4880 and the
glutathione peroxidase 1 single nucleotide polymorphism rs1050450 areassociated with aging and longevity in the oldest old. Mech Ageing Dev
2009, 130(5):308–314.
27. Ravn-Haren G, Olsen A, Tjønneland A, Dragsted LO, Nexø BA, Wallin H,
Overvad K, Raaschou- Nielsen O, Vogel U: Associations between GPX1
Pro198Leu polymorphism, erythrocyte GPX activity, alcohol
consumption and breast cancer risk in a prospective cohort study.
Carcinogenesis 2006, 27(4):820–825.
28. Pera J, Slowik A, Dziedzic T, Pulyk R, Wloch D, Szczudlik A: Glutathione
peroxidase 1 C593T polymorphism is associated with lobar intracerebral
hemorrhage. Cerebrovasc Dis 2008, 25(5):445–449.
29. Coffey DM, Marmol L, Schock L, Adams W: The influence of acculturation
on the Wisconsin card sorting test by Mexican Americans. Arch Clin
Neuropsychol 2005, 20(6):795–803.
30. Tang NP, Wang LS, Yang L, Gu HJ, Sun QM, Cong RH, Zhou B, Zhu HJ:
Reliant artery disease in a Chinese population. Clin Chim Acta 2008,
395(1–2):89–93.
31. U.S. Interim projections by Age, Sex, race, and Hispanic origin. http://www.
census.gov/ipc/www/usinterimproj/.
32. Chen J, Cao Q, Qin C, Shao P, Wu Y, Wang M, Zhang Z, Yin C: GPx-1
polymorphism (rs1050450) contributes to tumor susceptibility: evidence
from meta-analysis. J Cancer Res Clin Oncol 2011, 137(10):1553–1561.
33. Cominetti C, de Bortoli MC, Purgatto E, Ong TP, Moreno FS, Garrido AB,
Cozzolino SMF: Associations between glutathione peroxidase-1
Pro198Leu polymorphism, selenium status, and DNA damage levels in
obese women after consumption of brazil nuts. Nutrition 2011,
27(9):891–896.
34. O’Fallon LR, Dearry A: Commitment of the national institute of
environmental health sciences to community-based participatory
research for rural health. Environ Health Perspect 2001, 109:469–473.
35. O’Bryant S, Edwards M, Menon CV, Gong G, Barber R: Long-term low-level
arsenic exposure is associated with poorer neuropsychological
functioning: a project FRONTIER study. Int J Environ Res Public Health 2011,
8:861–874.
36. Hall J, Edwards M, Barber RC, Johnson LA, Gong G, O’Bryant SE: Higher
groundwater selenium exposure is associated with better memory: a
project FRONTIER study. Neurosci and Med 2012, 3(1):8–25.
37. Johnson LA, Hobson V, Jenkins M, Dentino A, Ragain M, O’Bryant S: The
influence of thyroid function on cognition in a sample of ethnically
diverse, rural-dwelling women: a project frontier study. J Neuropsychiatry
Clin Neurosci 2011, 23(2):219–222.
38. Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a
geriatric depression screening scale: a preliminary report. J Psychiatr Res
1982, 17:37–49.
39. Mui AC: Geriatric depression scale as a community screening instrument
for elderly Chinese immigrants. Int Psychogeriatr 1996, 8(3):445–458.
40. Hall J, Davis TE: Factor structure of the geriatric depression scale in
cognitive impaired older adults. Clin Gerontol 2010, 33:39–48.
41. Gong G, O’Bryant SE: The arsenic exposure hypothesis for Alzheimer’s
disease. Alzheimer Dis Assoc Disord 2010, 24(4):311–316.
42. AvRuskin GA, Jacquez GM, Meliker JR, Slotnick MJ, Kaufmann AM, Nriagu JO:
Visualization and exploratory analysis of epidemiologic data using a
novel space time information system. Int J Heal Geogr 2004, 3:art. no. 26.
43. Su CC, Lin YY, Chang TK, Chiang CT, Chung JA, Hsu YY, Lian IB: Incidence of
oral cancer in relation to nickel and arsenic concentrations in farm soils
of patients’ residential areas in Taiwan. BMC Publ Health 2010,
10: art. no. 67.
44. Khan NI, Owens G, Bruce D, Naidu R: Human arsenic exposure and risk
assessment at the landscape level: a review. Environ Geochem Heal 2009,
31(SUPPL. 1):143–166.
45. Samadder SR, Subbarao C: GIS approach of delineation and risk
assessment of areas affected by arsenic pollution in drinking water.
J Environ Eng 2007, 133(7):742–749.
46. Gong G, Hargrave KA, Hobson V, Spallholz J, Boylan M, Lefforge D, O’Bryant
SE: Low-level groundwater arsenic exposure impacts cognition: a project
FRONTIER study. J Environ Health 2011, 74(2):16–22.
47. Chen J, Berry MJ: Selenium and selenoproteins in the brain and brain
diseases. J Neurochem 2003, 86(1):1–12.
48. Barceloux DG: Selenium. J Toxicol Clin Toxicol 1999, 37(2):145–172.
49. Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE: Selenium and
brain function: a poorly recognized liaison. Brain Res Rev 2004,
45(3):164–178.
Johnson et al. BMC Psychiatry 2013, 13:7 Page 8 of 8
http://www.biomedcentral.com/1471-244X/13/750. Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni J, Freitas AE,
Farina M, Rodrigues AL: Ascorbic acid treatment, similarly to fluoxetine,
reverses depressive-like behavior and brain oxidative damage induced
by chronic unpredictable stress. J Psychiatr Res 2012, 46(3):331–340.
51. Abdel-Wahab BA, Salama RH: Venlafaxine protects against stress-induced
oxidative DNA damage in hippocampus during antidepressant testing in
mice. Pharmacol Biochem Behav 2011, 100(1):59–65.
52. Green A, Garrick T, Sheedy D, Blake H, Shores A, Harper C: Repeatable
battery for the assessment of neuropsychological status (RBANS):
preliminary Australian normative data. Aust J Psychol 2008, 60(2):72–79.
53. Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M,
Szemraj J: Association between inducible and neuronal nitric oxide
synthase polymorphisms and recurrent depressive disorder. J Affect
Disord 2011, 129(1–3):175–182.
doi:10.1186/1471-244X-13-7
Cite this article as: Johnson et al.: The impact of GPX1 on the
association of groundwater selenium and depression: a project
FRONTIER study. BMC Psychiatry 2013 13:7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
